Research suggests only small percentage of patients who stop therapy due to FDA warning switch to another medication - Sacramento Bee

Researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark, reviewed the impact of an FDA communication made on January 25, 2008 regarding the cholesterol-lowering medication, ezetimibe. The FDA issued an early ...

Aortic stenosis: Vytorin does not slow progression of aortic valve disease - Xagena Medical News

The SEAS ( Simvastatin and Ezetimibe in Aortic Stenosis ) study has investigated the effects of intensive cholesterol lowering with the combination of Simvastatin ( 40 dmg daily ) and Ezetimibe ( 10 mg daily ) ( Inegy, Vytorin ) in patients with aortic stenosis.

CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety - Boston Globe

Researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark, reviewed the impact of an FDA communication made on January 25, 2008 regarding the cholesterol-lowering medication, ezetimibe. The FDA issued an early ...

FDA to investigate possible Vytorin-cancer link - Xagena Medical News

The FDA ( Food and Drug Administration ) is investigating a report from the SEAS trial ( Simvastatin and Ezetimibe in Aortic Stenosis ) of a possible association between the use of Vytorin ( a combination of Simvastatin plus Ezetimibe ) and a potentially ...

Merck: Will Singulair Expiration Sink Its Stock? - Seekingalpha.com

Merck has two more drugs under review, ridaforalimus for sarcoma, and combination drug, ezetimibe and atorvastatin, to prevent atherosclerosis by controlling cholesterol. There are 19 Merck drugs in Phase III trials, and 13 drugs in Phase II trials.

Quit Playing (Number) Games With My Heart? - huffingtonpost.ca

Other popular drugs (ezetimibe, niacin, fibrates) that lower cholesterol numbers have not been shown to consistently reduce the chance of cardiovascular events. Most blood pressure drugs (but not atenolol or doxazosin), according to JAMA, when used in ...

A New Drug in the Horizon to Increase HDL Good Cholesterol levels - PR-USA.net

Some of the cholesterol lowering drugs in BMD product range is Lipitor (atorvastatin), Mevacor (lovastatin), Advicor (niacin / lovastatin), Omacor (omega 3 acid ethyl esters), Zocor (simvastatin) and Vytorin (ezetimibe/simvastatin). They also carry ...